Pomdoctor Limited American Stock Performance
| POM Stock | 0.31 0.01 3.13% |
The company holds a Beta of -3.18, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning POMDOCTOR LIMITED are expected to decrease by larger amounts. On the other hand, during market turmoil, POMDOCTOR LIMITED is expected to outperform it. At this point, POMDOCTOR LIMITED has a negative expected return of -1.54%. Please make sure to check POMDOCTOR LIMITED's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if POMDOCTOR LIMITED performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days POMDOCTOR LIMITED American has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Worker Seriously Hurt After Georgetown Home Partially Collapses During Renovation In DC | 11/04/2025 |
2 | Rising Costs and Widespread Power Outages Strain Business Customer Satisfaction with Electric Utilities, J.D. Power Finds | 11/12/2025 |
3 | The curious case of why Poundland is struggling during a cost-of-living-crisis | 11/21/2025 |
4 | Exelon Announces Proposed Offering of 900 Million of Convertible Senior Notes due 2029 | 12/01/2025 |
5 | POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results | 12/03/2025 |
6 | Every Poundland store set to close in 2026 - full list | 12/12/2025 |
7 | Poundland to tap emergency overdraft after Christmas trading slump | 12/24/2025 |
8 | Exelon to Announce Fourth Quarter Results on Feb. 12 | 01/05/2026 |
9 | 10 iconic high street brands close hundreds of stores with dozens more at risk | 01/13/2026 |
| Begin Period Cash Flow | 6.8 M | |
| Total Cashflows From Investing Activities | -33.4 K |
POMDOCTOR | Build AI portfolio with POMDOCTOR Stock |
POMDOCTOR LIMITED Relative Risk vs. Return Landscape
If you would invest 428.00 in POMDOCTOR LIMITED American on October 18, 2025 and sell it today you would lose (397.00) from holding POMDOCTOR LIMITED American or give up 92.76% of portfolio value over 90 days. POMDOCTOR LIMITED American is generating negative expected returns assuming volatility of 14.2586% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than POMDOCTOR, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
POMDOCTOR LIMITED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for POMDOCTOR LIMITED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as POMDOCTOR LIMITED American, and traders can use it to determine the average amount a POMDOCTOR LIMITED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1083
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | POM |
Based on monthly moving average POMDOCTOR LIMITED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of POMDOCTOR LIMITED by adding POMDOCTOR LIMITED to a well-diversified portfolio.
POMDOCTOR LIMITED Fundamentals Growth
POMDOCTOR Stock prices reflect investors' perceptions of the future prospects and financial health of POMDOCTOR LIMITED, and POMDOCTOR LIMITED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on POMDOCTOR Stock performance.
| Price To Earning | 22.44 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 342.56 M | ||||
| EBITDA | (24.27 M) | ||||
| Net Income | (37.37 M) | ||||
| Cash And Equivalents | 57 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 441.1 M | ||||
| Debt To Equity | 1.36 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | 21.28 X | ||||
| Cash Flow From Operations | (16.13 M) | ||||
| Market Capitalization | 6.6 B | ||||
| Total Asset | 46.23 M | ||||
| Retained Earnings | (2.26 B) | ||||
| Working Capital | (141.65 M) | ||||
| Current Asset | 1.2 B | ||||
| Current Liabilities | 2.31 B | ||||
About POMDOCTOR LIMITED Performance
By examining POMDOCTOR LIMITED's fundamental ratios, stakeholders can obtain critical insights into POMDOCTOR LIMITED's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that POMDOCTOR LIMITED is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 13.05 | 17.24 | |
| Return On Tangible Assets | (2.79) | (2.93) | |
| Return On Capital Employed | 0.22 | 0.36 | |
| Return On Assets | (2.79) | (2.93) | |
| Return On Equity | 0.07 | 0.08 |
Things to note about POMDOCTOR LIMITED performance evaluation
Checking the ongoing alerts about POMDOCTOR LIMITED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for POMDOCTOR LIMITED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| POMDOCTOR LIMITED generated a negative expected return over the last 90 days | |
| POMDOCTOR LIMITED has high historical volatility and very poor performance | |
| POMDOCTOR LIMITED has some characteristics of a very speculative penny stock | |
| POMDOCTOR LIMITED has a very high chance of going through financial distress in the upcoming years | |
| POMDOCTOR LIMITED American has 441.1 M in debt with debt to equity (D/E) ratio of 1.36, which is OK given its current industry classification. POMDOCTOR LIMITED has a current ratio of 0.51, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for POMDOCTOR to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 342.56 M. Reported Net Loss for the year was (37.37 M) with profit before taxes, overhead, and interest of 0. | |
| POMDOCTOR LIMITED American has about 57 M in cash with (16.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Latest headline from express.co.uk: 10 iconic high street brands close hundreds of stores with dozens more at risk |
- Analyzing POMDOCTOR LIMITED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether POMDOCTOR LIMITED's stock is overvalued or undervalued compared to its peers.
- Examining POMDOCTOR LIMITED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating POMDOCTOR LIMITED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of POMDOCTOR LIMITED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of POMDOCTOR LIMITED's stock. These opinions can provide insight into POMDOCTOR LIMITED's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in POMDOCTOR LIMITED American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceutical Retailers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of POMDOCTOR LIMITED. If investors know POMDOCTOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about POMDOCTOR LIMITED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of POMDOCTOR LIMITED is measured differently than its book value, which is the value of POMDOCTOR that is recorded on the company's balance sheet. Investors also form their own opinion of POMDOCTOR LIMITED's value that differs from its market value or its book value, called intrinsic value, which is POMDOCTOR LIMITED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because POMDOCTOR LIMITED's market value can be influenced by many factors that don't directly affect POMDOCTOR LIMITED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between POMDOCTOR LIMITED's value and its price as these two are different measures arrived at by different means. Investors typically determine if POMDOCTOR LIMITED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, POMDOCTOR LIMITED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.